This review highlights the complex pathophysiology of dyslipidemia in type 1 and type 2 diabetes and emphasizes the need for aggressive lipid management to prevent atherosclerotic cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Subtype-specific lipid strategies may aid diabetes care; leaves open dedicated outcome trials.
Henry N. Ginsberg (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: